OB/GYN Clinical Alert – August 1, 2011

August 1, 2011

• Progestins and Risk of Venous Thromboembolism: What's the Deal with Drospirenone?

  Two independent case-control studies investigating the risk of venous thromboembolism (VTE) in users of oral contraceptives (OC) containing 30 mcg of ethinyl estradiol and a progestin component of either drospirenone or levonorgestrel found that VTE risk was two to three times higher in those using a drospirenone pill.

  Read more

• Term Pregnancy

  The concept that "term" pregnancy applies to any pregnancy extending past 36 completed weeks has been recently strongly challenged.

  Read more

• What To Do About Microscopic Hematuria

  This case-driven discussion of microscopic hematuria includes important guidelines, definitions, and reminders to aid the clinician in managing this common finding.

  Read more

• Is it Time to Change the Standard of Care for Low-risk GTN?

  There are at least six different commonly used chemotherapeutic regimens in practice to treat patients with low-risk gestational trophoblastic neoplasia (GTN) with no consensus or previous formal evaluation as to which may be best.

  Read more

• Pharmacology Watch: FDA issues Multiple Drug Warnings

  In this issue: FDA issues multiple drug safety alerts; ARBs and cancer risk; and FDA actions.

  Read more

• Clinical Briefs in Primary Care supplement

  Read more